Peptides

Tesamorelin

Fat & Metabolism

This product is made from peptide analogs of growth hormone-releasing hormone (GHRH), TNF-α, and antimicrobial peptides.

Tesamorelin is used clinically to reduce visceral fat by stimulating endogenous growth hormone release through activation of GHRH receptors.

It is primarily applied in patients with lipodystrophy or metabolic dysfunction to improve body composition, decrease abdominal fat, and enhance insulin sensitivity.

Additional clinical applications include supporting lean muscle preservation, improving IGF-1 levels, and contributing to overall metabolic health and energy utilization.

Benefits:

Visceral Fat Reduction.
Increased Growth Hormone Secretion.
Improved IGF-1 Levels.
Enhanced Fat Metabolism.
Improved Insulin Sensitivity.
Lean Muscle Preservation.
Better Body Composition.

Price:

$13500 MXN, $794 USD (Price per box of 3 vials)

Details:

Mechanism of action: GH and reduction of visceral fat.
Clinical applications: HIV, HIV-associated lipodystrophy, insulin resistance, and sarcopenia.
Therapeutic category: Hormonal.
Route of administration: Subcutaneous (SC) and Intramuscular (IM).
Dosage: 1 mg.
Frequency of application: Daily.
Administration: Subcutaneous injection (Download Guide)